NOBIVAC® Intra-Trac®₃ ADT

Intra-Trac^®₃ ADT

NOBIVAC^® Intra-Trac^®₃ ADT is an intranasal vaccine that provides triple protection with Advanced Delivery Technology (ADT).

Product Description

NOBIVAC^® INTRA-TRAC^®₃ ADT provides protection against Tracheobronchitis (“Canine Cough”)

Canine Adenovirus 2, Canine Parainfluenza Virus (modified live viruses), Bordetella Bronchiseptica (avirulent live culture).

Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2
ADT eliminates the possibility of accidental injection
Offers the superior benefits of intranasal administration
- Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
- Requires only single-nostril administration—low dose of 0.5 mL
- Provides rapid protection beginning as early as 48 hours post-vaccination against B. bronchiseptica¹⁴
- Proven 1-year duration of immunity for B. bronchiseptica¹⁵

product Label

Overview

Indications

This product has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica.

ADMINISTRATION AND DOSAGE

Designed for intranasal use only with the enclosed applicators
Using supplied nasal applicator, instill 1 dose (0.5 mL) into one or both nostrils
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
Available in two presentations: 25 x 1, 150 x 1 dose

ALSO AVAILABLE IN OTHER FORMULATIONS

NOBIVAC® Intra-Trac®₃

DISEASE INFORMATION

Canine Infectious Respiratory Disease Complex (CIRDC)

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

View More Nobivac® Resources

Infographic

Pair Up for Protection

When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients

Download

Digital Assets